Photodynamic therapy using verteporfin-induced minimal change nephrotic syndrome

Shin-Wook Kang, Shin J. Kang, Hyun O. Kim, Eun S. Nam, Jin H. Lee, Hyoung J. Koh

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

PURPOSE: To report a case of minimal change nephrotic syndrome (MCNS) after photodynamic therapy using verteporfin. DESIGN: Interventional case report. METHODS: After four cycles of photodynamic therapy, general weakness with generalized edema developed in an otherwise healthy 66-year-old woman, resulting in dyspnea and ascites. Urinalysis showed heavy proteinuria (4+) with decreased serum total protein and albumin, and increased total cholesterol levels, suggesting nephrotic syndrome. Renal biopsy and pathologic diagnosis were performed. RESULTS: Renal biopsy revealed normal glomeruli and tubulointerstitium by light microscopy, with no immunoglobin or complement deposition. Transmission electron microscopy showed diffuse effacement of the foot processes of visceral epithelial cells, which is the characteristic finding of minimal change nephrotic syndrome. CONCLUSIONS: We herein report a case of minimal change nephrotic syndrome after photodynamic therapy using verteporfin.

Original languageEnglish
Pages (from-to)907-908
Number of pages2
JournalAmerican Journal of Ophthalmology
Volume134
Issue number6
DOIs
Publication statusPublished - 2002 Dec 1

Fingerprint

Lipoid Nephrosis
Photochemotherapy
Kidney
Biopsy
Urinalysis
Nephrotic Syndrome
Transmission Electron Microscopy
Proteinuria
Ascites
Serum Albumin
Dyspnea
Foot
Blood Proteins
Microscopy
Edema
Epithelial Cells
Cholesterol
Light
verteporfin

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

Kang, Shin-Wook ; Kang, Shin J. ; Kim, Hyun O. ; Nam, Eun S. ; Lee, Jin H. ; Koh, Hyoung J. / Photodynamic therapy using verteporfin-induced minimal change nephrotic syndrome. In: American Journal of Ophthalmology. 2002 ; Vol. 134, No. 6. pp. 907-908.
@article{932d28b40017462ea2b2ca627e10794f,
title = "Photodynamic therapy using verteporfin-induced minimal change nephrotic syndrome",
abstract = "PURPOSE: To report a case of minimal change nephrotic syndrome (MCNS) after photodynamic therapy using verteporfin. DESIGN: Interventional case report. METHODS: After four cycles of photodynamic therapy, general weakness with generalized edema developed in an otherwise healthy 66-year-old woman, resulting in dyspnea and ascites. Urinalysis showed heavy proteinuria (4+) with decreased serum total protein and albumin, and increased total cholesterol levels, suggesting nephrotic syndrome. Renal biopsy and pathologic diagnosis were performed. RESULTS: Renal biopsy revealed normal glomeruli and tubulointerstitium by light microscopy, with no immunoglobin or complement deposition. Transmission electron microscopy showed diffuse effacement of the foot processes of visceral epithelial cells, which is the characteristic finding of minimal change nephrotic syndrome. CONCLUSIONS: We herein report a case of minimal change nephrotic syndrome after photodynamic therapy using verteporfin.",
author = "Shin-Wook Kang and Kang, {Shin J.} and Kim, {Hyun O.} and Nam, {Eun S.} and Lee, {Jin H.} and Koh, {Hyoung J.}",
year = "2002",
month = "12",
day = "1",
doi = "10.1016/S0002-9394(02)01752-X",
language = "English",
volume = "134",
pages = "907--908",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "6",

}

Photodynamic therapy using verteporfin-induced minimal change nephrotic syndrome. / Kang, Shin-Wook; Kang, Shin J.; Kim, Hyun O.; Nam, Eun S.; Lee, Jin H.; Koh, Hyoung J.

In: American Journal of Ophthalmology, Vol. 134, No. 6, 01.12.2002, p. 907-908.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Photodynamic therapy using verteporfin-induced minimal change nephrotic syndrome

AU - Kang, Shin-Wook

AU - Kang, Shin J.

AU - Kim, Hyun O.

AU - Nam, Eun S.

AU - Lee, Jin H.

AU - Koh, Hyoung J.

PY - 2002/12/1

Y1 - 2002/12/1

N2 - PURPOSE: To report a case of minimal change nephrotic syndrome (MCNS) after photodynamic therapy using verteporfin. DESIGN: Interventional case report. METHODS: After four cycles of photodynamic therapy, general weakness with generalized edema developed in an otherwise healthy 66-year-old woman, resulting in dyspnea and ascites. Urinalysis showed heavy proteinuria (4+) with decreased serum total protein and albumin, and increased total cholesterol levels, suggesting nephrotic syndrome. Renal biopsy and pathologic diagnosis were performed. RESULTS: Renal biopsy revealed normal glomeruli and tubulointerstitium by light microscopy, with no immunoglobin or complement deposition. Transmission electron microscopy showed diffuse effacement of the foot processes of visceral epithelial cells, which is the characteristic finding of minimal change nephrotic syndrome. CONCLUSIONS: We herein report a case of minimal change nephrotic syndrome after photodynamic therapy using verteporfin.

AB - PURPOSE: To report a case of minimal change nephrotic syndrome (MCNS) after photodynamic therapy using verteporfin. DESIGN: Interventional case report. METHODS: After four cycles of photodynamic therapy, general weakness with generalized edema developed in an otherwise healthy 66-year-old woman, resulting in dyspnea and ascites. Urinalysis showed heavy proteinuria (4+) with decreased serum total protein and albumin, and increased total cholesterol levels, suggesting nephrotic syndrome. Renal biopsy and pathologic diagnosis were performed. RESULTS: Renal biopsy revealed normal glomeruli and tubulointerstitium by light microscopy, with no immunoglobin or complement deposition. Transmission electron microscopy showed diffuse effacement of the foot processes of visceral epithelial cells, which is the characteristic finding of minimal change nephrotic syndrome. CONCLUSIONS: We herein report a case of minimal change nephrotic syndrome after photodynamic therapy using verteporfin.

UR - http://www.scopus.com/inward/record.url?scp=0036897319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036897319&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(02)01752-X

DO - 10.1016/S0002-9394(02)01752-X

M3 - Article

C2 - 12470762

AN - SCOPUS:0036897319

VL - 134

SP - 907

EP - 908

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 6

ER -